1van der Bij W, Speich R. Management of cytomegalovirus infection and disease after solid-organ transplantation. Clin Infect Dis, 2001, 33(Suppl 1): S33
3Fetterman GH. New laboratory aid in clinical diagnosis of inclusion disease of infancy. Am J Clin Pathol, 1952, 22 (5): 424
4Gleaves CA, Smith TF, Shuster EA, et al. Rapid detection of cytomegalovirus in MRC-5 cells inoculated with urine specimens by using low-speed centrifugation and monoclonal antibody to an early antigen. J Clin Microbiol, 1984, 19(6):917
5Gleaves CA, Smith TF, Shuster EA, et al. Comparison of standard tube and shell vial cell culture techniques for the detection of cytomegalovirus in clinical specimens. J Clin Microbiol, 1985, 21(2):217
7Schmidt CA, Oettle H, Peng R, et al. Comparison of polymerase chain reaction for plasma and buffy coat with antigen detection and occurrence of immunoglobulin M for detection of cytomegalovirus infection after liver transplantation. Transplantation, 1995, 59(8):1133
8van der Bij W, van Dijk RB, van Son WJ, et al. Antigen test for early diagnosis of active cytomegalovirus infection in heart transplant recipients. J Heart Transplant, 1988, 7(2):106
9Grefte JM, van der Gun BT, Schmolke S, et al. The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection. J Gen Virol, 1992, 73 ( Pt 11):2923
10Solano C, Munoz I, Gutierrez A, et al. Qualitative plasma PCR assay (Amplicor CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovior therapy in allogeneic stem cell transplantation. J Clin Microbiol, 2001, 39 (11):3938
4Boeckh M,Gooley TA,Myerson D,et al.Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir Versus Ganciclovin at engraftment after allogeneic marrow transplantation:arandomized double-blind study[].Blood.1996
5Hibberd PL,Tolkoff-Rubin NE,Conti D,et al.Preemptive ganciclovir therapy to prevent cytomegalovirus disease in Cytomegalovivus antibody-positive renal transplant recipients[].Annals of Internal Medicine.1995
6Turgeon N,Fishman JA,Nesli Basgoz N,et al.Effect of oral acyclovir or ganciclovir therapy after preemptive intravenous ganciclovir therapy to prevent cytomegalovirus diseases in cytomegalovirus seropositive renal and liver transplant recipients receiving antilymphocyte antibody therapy[].Transplantation.1998
